Frank Boschelli

Summary

Affiliation: Wyeth Research
Country: USA

Publications

  1. ncbi A cell-based screen for inhibitors of protein folding and degradation
    Frank Boschelli
    Department of Oncology, Wyeth Research now the Center for Integrative Biology and Biotherapeutics, Pfizer R and D, 401 N Middletown Rd, Pearl River, NY 10965, USA
    Cell Stress Chaperones 15:913-27. 2010
  2. ncbi Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia
    Frank Boschelli
    Department of Oncology, Wyeth Research Wyeth Research is Now Pfizer Research, Pearl River, NY, USA
    Eur J Cancer 46:1781-9. 2010
  3. ncbi Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles
    Diane H Boschelli
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 48:3891-902. 2005
  4. ncbi 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors
    Dan M Berger
    Chemical and Screening Sciences and Oncology, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 48:5909-20. 2005
  5. ncbi Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model
    Christoph W Zapf
    Medicinal Chemistry, Pfizer, Pearl River, NY 10965, United States
    Bioorg Med Chem Lett 21:3627-31. 2011
  6. ncbi SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models
    Jennifer M Golas
    Department of Oncology, Wyeth Research, Pearl River, New York 10965, USA
    Cancer Res 65:5358-64. 2005
  7. ncbi Investigation of the effect of varying the 4-anilino and 7-alkoxy groups of 3-quinolinecarbonitriles on the inhibition of Src kinase activity
    Diane H Boschelli
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 13:3797-800. 2003
  8. ncbi Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles
    Diane H Boschelli
    Chemical and Screening Sciences and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, NY 10965, USA
    J Med Chem 49:7868-76. 2006
  9. ncbi Facile preparation of new 4-phenylamino-3-quinolinecarbonitrile Src kinase inhibitors via 7-fluoro intermediates: identification of potent 7-amino analogs
    Diane H Boschelli
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem 16:405-12. 2008
  10. ncbi 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases
    Diane H Boschelli
    Chemical and Screening Sciences and Oncology, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 47:1599-601. 2004

Detail Information

Publications30

  1. ncbi A cell-based screen for inhibitors of protein folding and degradation
    Frank Boschelli
    Department of Oncology, Wyeth Research now the Center for Integrative Biology and Biotherapeutics, Pfizer R and D, 401 N Middletown Rd, Pearl River, NY 10965, USA
    Cell Stress Chaperones 15:913-27. 2010
    ..When used in conjunction with appropriate secondary assays, this screen is a powerful cell-based tool for studying compounds that affect protein synthesis, folding, and degradation...
  2. ncbi Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia
    Frank Boschelli
    Department of Oncology, Wyeth Research Wyeth Research is Now Pfizer Research, Pearl River, NY, USA
    Eur J Cancer 46:1781-9. 2010
    ..This review will focus on preclinical studies supporting the clinical development of bosutinib for treatment of CML, with a discussion on the broader potential of this agent in other oncology indications...
  3. ncbi Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles
    Diane H Boschelli
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 48:3891-902. 2005
    ..One of the analogues reported here exhibited in vivo activity comparable to that of SKI-606, a related 3-quinolinecarbonitrile currently in clinical trials...
  4. ncbi 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors
    Dan M Berger
    Chemical and Screening Sciences and Oncology, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 48:5909-20. 2005
    ..In an Src-transformed fibroblast xenograft model, both compounds exhibited a significant inhibition of tumor growth...
  5. ncbi Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model
    Christoph W Zapf
    Medicinal Chemistry, Pfizer, Pearl River, NY 10965, United States
    Bioorg Med Chem Lett 21:3627-31. 2011
    ..When studied in a xenograft model, the compound demonstrated significant suppression of tumor growth...
  6. ncbi SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models
    Jennifer M Golas
    Department of Oncology, Wyeth Research, Pearl River, New York 10965, USA
    Cancer Res 65:5358-64. 2005
    ..These results support development of SKI-606 as a therapeutic agent for treatment of colorectal cancer...
  7. ncbi Investigation of the effect of varying the 4-anilino and 7-alkoxy groups of 3-quinolinecarbonitriles on the inhibition of Src kinase activity
    Diane H Boschelli
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 13:3797-800. 2003
    ..Compound 18, which has a 1-methylpiperidinemethoxy group at C-7, showed in vivo activity in a xenograft model...
  8. ncbi Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles
    Diane H Boschelli
    Chemical and Screening Sciences and Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, NY 10965, USA
    J Med Chem 49:7868-76. 2006
    ..The kinase selectivity profile of 10 was similar to that of 1, with 10 also inhibiting the activity of Abl and Lck. When tested in a solid tumor xenograft model, 10 had comparable oral activity to that of 1...
  9. ncbi Facile preparation of new 4-phenylamino-3-quinolinecarbonitrile Src kinase inhibitors via 7-fluoro intermediates: identification of potent 7-amino analogs
    Diane H Boschelli
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem 16:405-12. 2008
    ..In addition, the fluoro group of 2 was readily displaced by primary and secondary amines to give 7-amino analogs. Two of these 7-amino analogs, 15 and 18, were potent Src inhibitors with in vivo activity...
  10. ncbi 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases
    Diane H Boschelli
    Chemical and Screening Sciences and Oncology, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 47:1599-601. 2004
    ..We disclose here a new highly efficient and versatile route to these compounds, which are also potent inhibitors of Abl kinase...
  11. ncbi Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles
    Diane H Boschelli
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 15:4681-4. 2005
    ..Of these new analogs, compounds substituted at C-2 by a 3,5-furan or a 2,5-pyridine had the best activity in the Src enzyme and cell assays...
  12. ncbi Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors
    Diane H Boschelli
    Wyeth Research, Chemical Sciences 401 N Middletown Road, Pearl River, NY 10965, United States
    Bioorg Med Chem Lett 20:2924-7. 2010
    ..The 7-alkene-3-quinolinecarbonitrile 20, a potent inhibitor of Src enzymatic and cellular activity with IC(50) values of 2.1 and 58 nM, respectively, had comparable efficacy to bosutinib in a colon tumor xenograft study...
  13. ncbi 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors
    Nan Zhang
    Chemical Sciences, Wyeth Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 19:5071-4. 2009
    ..The lead compound, 17, showed potent activity in both the Src enzyme assay and cell assays, and demonstrated in vivo anti-tumor activity in a xenograft model...
  14. ncbi Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model
    Christoph W Zapf
    Medicinal Chemistry, Pfizer, Pearl River, NY 10965, United States
    Bioorg Med Chem Lett 21:4602-7. 2011
    ..When studied in a lung cancer xenograft model, the compound demonstrated significant tumor size reduction...
  15. ncbi Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activity
    Christoph W Zapf
    Medicinal Chemistry, Pfizer, 401 N Middletown Road, Pearl River, NY 10965, United States
    Bioorg Med Chem Lett 21:3411-6. 2011
    ..This compound showed prolonged Hsp90-inhibitory activity at least 24 h post-administration, consistent with elevated and prolonged exposure in the tumor...
  16. ncbi Substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles as Src kinase inhibitors
    Dan Berger
    Chemical Sciences, Wyeth Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 12:2989-92. 2002
    ..The best compounds are low nanomolar inhibitors of Src kinase, and have potent activity against Src-transformed fibroblast cells...
  17. ncbi SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice
    Jennifer M Golas
    Departments of Oncology, Wyeth Research, Pearl River, New York 10965, USA
    Cancer Res 63:375-81. 2003
    ..Once daily oral administration of this compound at 100 mg/kg for 5 days causes complete regression of large K562 xenografts in nude mice...
  18. ncbi 8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src kinase inhibitors
    Dan Berger
    Chemical Sciences, Wyeth Ayerst Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 12:2761-5. 2002
    ..Several aniline substituents were surveyed, as well as water-solubilizing groups at the C-2 and N-3 positions. Potent Src inhibitors were identified, with N-3 providing the best position for an additional water-solubilizing group...
  19. ncbi Inhibition of Src kinase activity by 4-anilino-5,10-dihydro-pyrimido[4,5-b]quinolines
    Diane H Boschelli
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 13:2977-80. 2003
    ..The corresponding 4-(2,4-dichloro-5-methoxy)anilino-pyrimido[4,5-b]quinolines are much less effective Src inhibitors...
  20. ncbi Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of SKS-927
    Diane H Boschelli
    Wyeth Research, Chemical and Screening Sciences, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 17:1358-61. 2007
    ..Variation of the solubilizing amine tail or removal of the methoxy group from either C-6 of the quinoline core or C-5 of the aniline headpiece led to reduced activity...
  21. ncbi Identification of 7-phenylaminothieno- [3,2-b]pyridine-6-carbonitriles as a new class of Src kinase inhibitors
    Diane H Boschelli
    Chemical and Screening Sciences and Oncology, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 47:6666-8. 2004
    ..When suitably substituted, the resultant 7-phenylaminothieno[3,2-b]pyridine-6-carbonitrile analogues show potent inhibition of Src kinase activity...
  22. ncbi 7-(aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles as new Src kinase inhibitors: addition of water solubilizing groups
    Biqi Wu
    Department of Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 16:3993-7. 2006
    ....
  23. ncbi Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90
    Ariamala Gopalsamy
    Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA
    J Med Chem 51:373-5. 2008
    ..Crystallographic studies show that these compounds bind in the ATP binding pocket interacting with the Asp93. Structure based optimization led to the identification of potent analogues, such as 13, with good biochemical profiles...
  24. ncbi Synthesis and inhibition of Src kinase activity by 7-ethenyl and 7-ethynyl-4-anilino-3-quinolinecarbonitriles
    Ana Carolina Barrios Sosa
    Wyeth Research, Chemical and Screening Sciences, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 14:2155-8. 2004
    ..The ethenyl and ethynyl groups were incorporated at C-7 utilizing a Stille, Heck, or Sonogashira coupling reaction...
  25. ncbi Inhibition of Src kinase activity by 4-anilino-7-thienyl-3-quinolinecarbonitriles
    Diane H Boschelli
    Wyeth Research, Chemical Sciences and Oncology, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 12:2011-4. 2002
    ..When the thiophene ring was substituted with a water-solubilizing group in a 2,5-, 3,5- or 2,4-pattern, potent inhibition of Src kinase activity was observed...
  26. ncbi Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity
    Christoph W Zapf
    Medicinal Chemistry, Pfizer, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 21:2278-82. 2011
    ..Important structure-activity relationship information was obtained from this series which led to the discovery of a soluble and stable compound which is potent in an Hsp90 binding and cell-proliferation assay...
  27. ncbi 4-Anilino-3-cyanobenzo[g]quinolines as kinase inhibitors
    Nan Zhang
    Chemical Sciences, Wyeth Ayerst Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 12:423-5. 2002
    ..For Src kinase inhibition, the best activity is obtained when both the 7- and 8-positions are substituted with alkoxy groups. Several of these kinase inhibitors show potent growth inhibitory activity in tumor cells...
  28. ncbi Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment
    Lori M Miller
    Wyeth Research, Chemical and Screening Sciences, Princeton, NJ, USA
    Bioorg Med Chem Lett 19:62-6. 2009
    ..Now we have identified a series of 3-cyanoquinoline compounds that are low nanomolar inhibitors of IGF-1R. The strategies, synthesis, and SAR behind the cyanoquinoline scaffold will be discussed...
  29. ncbi Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment
    Scott C Mayer
    Wyeth Research, Chemical and Screening Sciences, 865 Ridge Road, Monmouth Junction, Princeton, NJ 08852, USA
    Bioorg Med Chem Lett 18:3641-5. 2008
    ..The strategies, synthesis, and SAR behind this interesting kinase scaffold will be described...
  30. ncbi Identification of a conserved sequence motif that promotes Cdc37 and cyclin D1 binding to Cdk4
    Qiang Zhao
    Department of Oncology, Wyeth Research, 401 North Middletown Road, Pearl River, NY 10965, USA
    J Biol Chem 279:12560-4. 2004
    ..Under the same conditions, p16 binding to wild type Cdk4 was suppressed. Our findings show that the interaction of Cdc37 with its client protein kinases requires amino acid residues within a motif that is present in many protein kinases...